Evidence map›Paper›PMID 36059693›Full record

ArticleFrontiers in oncology2022

Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma.

Feihang Wang, Shaonan Fan, Qin Shi, Danyang Zhao, Huiyi Sun, Yav Sothea, Mengfei Wu, Huadan Song, Yi Chen, Jiemin Cheng and 4 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Feihang WangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shaonan FanDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Qin ShiDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Danyang ZhaoDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Huiyi SunShanghai Medical College, Fudan University, Shanghai, China.
Yav SotheaDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Mengfei WuDepartment of Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), Third Hospital of Hebei Medical University, Shijiazhuang, China.
Huadan SongDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yi ChenDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jiemin ChengDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhaochong ZengDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhiping YanDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jian HeDepartment of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lingxiao LiuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This retrospective study compares the clinical results of cone beam CT (CBCT)-guided thermal ablation with those of helical tomotherapy in hepatocellular carcinoma (HCC) patients with pulmonary metastases. Methods: A total of 110 patients undergoing thermal ablation or helical tomotherapy for pulmonary metastases from April 2014 to December 2020 were included in the study. The endpoints were local tumor progression-free survival (LTPFS), overall survival (OS), and complications. Univariate and multivariate analyses using the Cox proportional hazard model were conducted to identify independent factors (univariate: Results: The results of 106 patients were taken into the final analysis. The 1- and 3-year LTPFS rates were 50 and 19% for the thermal ablation group and 65 and 25% for the helical tomotherapy group. The median LTPFS in the thermal ablation group was 12.1 months, while it was 18.8 months in the helical tomotherapy group ( Conclusions: For pulmonary metastases from HCC, CBCT-guided thermal ablation and helical tomotherapy provided comparable clinical effects and safety.

Indexed as

comparisonhelical tomotherapyhepatocellular carcinomapulmonary metastasesthermal ablation

Identifiers

PMID36059693
PMCPMC9428507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.